DE69801196D1 - Indol- und Indazol-derivate, Verfahren zu deren Herstellung und sie enthaltende Zusammensetzungen - Google Patents

Indol- und Indazol-derivate, Verfahren zu deren Herstellung und sie enthaltende Zusammensetzungen

Info

Publication number
DE69801196D1
DE69801196D1 DE69801196T DE69801196T DE69801196D1 DE 69801196 D1 DE69801196 D1 DE 69801196D1 DE 69801196 T DE69801196 T DE 69801196T DE 69801196 T DE69801196 T DE 69801196T DE 69801196 D1 DE69801196 D1 DE 69801196D1
Authority
DE
Germany
Prior art keywords
preparation
indole
indazole
processes
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69801196T
Other languages
English (en)
Other versions
DE69801196T2 (de
Inventor
Gilbert Lavielle
Olivier Muller
Christine Vayssettes-Courchay
Jean-Jacques Descombes
Tony Verbeuren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69801196D1 publication Critical patent/DE69801196D1/de
Publication of DE69801196T2 publication Critical patent/DE69801196T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69801196T 1997-09-03 1998-09-01 Indol- und Indazol-derivate, Verfahren zu deren Herstellung und sie enthaltende Zusammensetzungen Expired - Fee Related DE69801196T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710939A FR2767827A1 (fr) 1997-09-03 1997-09-03 Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69801196D1 true DE69801196D1 (de) 2001-08-30
DE69801196T2 DE69801196T2 (de) 2002-03-14

Family

ID=9510710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69801196T Expired - Fee Related DE69801196T2 (de) 1997-09-03 1998-09-01 Indol- und Indazol-derivate, Verfahren zu deren Herstellung und sie enthaltende Zusammensetzungen

Country Status (20)

Country Link
US (2) US6020336A (de)
EP (1) EP0902027B1 (de)
JP (1) JPH11130773A (de)
CN (2) CN1087741C (de)
AT (1) ATE203531T1 (de)
AU (1) AU736602B2 (de)
BR (1) BR9803318A (de)
CA (1) CA2246485C (de)
DE (1) DE69801196T2 (de)
DK (1) DK0902027T5 (de)
ES (1) ES2162404T3 (de)
FR (1) FR2767827A1 (de)
GR (1) GR3036678T3 (de)
HK (1) HK1019738A1 (de)
HU (1) HUP9801977A1 (de)
NO (1) NO316271B1 (de)
NZ (1) NZ331683A (de)
PL (1) PL328323A1 (de)
PT (1) PT902027E (de)
ZA (1) ZA988072B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779073B2 (en) * 1998-12-23 2005-01-06 Nps Allelix Corp. Indole and indolizidine derivatives for the treatment of migraine
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
MXPA02010222A (es) 2000-04-18 2003-05-23 Agouron Pharma Pirazoles para inhibir proteina cinasa.
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
AU8125501A (en) 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
FR2829134B1 (fr) 2001-08-28 2006-11-24 Atofina Procede de preparation de (meth) acrylates d'alkylimidazolidone
US20030073672A1 (en) * 2001-09-05 2003-04-17 Breitenbucher J. Guy Method for treating allergies using substituted pyrazoles
WO2012086735A1 (ja) * 2010-12-22 2012-06-28 大正製薬株式会社 縮合複素環化合物
CN102617548A (zh) * 2011-01-31 2012-08-01 北京赛林泰医药技术有限公司 作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
WO2014102588A2 (en) * 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US20150252051A1 (en) * 2014-03-10 2015-09-10 Innov17 Llc Retinoic acid receptor-related orphan receptor modulators and uses thereof
US20150252022A1 (en) * 2014-03-10 2015-09-10 Innov17 Llc Retinoic acid receptor-related orphan receptor modulators and uses thereof
WO2018106667A1 (en) * 2016-12-05 2018-06-14 Microbiotix, Inc. Broad-spectrum inhibitors of filoviruses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
TW203049B (de) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
EP0597112A4 (en) * 1992-03-27 1994-06-22 Kyoto Pharma Ind Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB2289465A (en) * 1994-05-19 1995-11-22 Merck Sharp & Dohme Five-membered heteroaromatic 5-HT receptor agonists
AU694226B2 (en) * 1994-05-19 1998-07-16 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists
EP0804434A1 (de) * 1994-08-02 1997-11-05 MERCK SHARP & DOHME LTD. Azetidin, pyrrolidin-und piperidinderivate
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
WO1997006159A1 (en) * 1995-08-07 1997-02-20 Merck Sharp & Dohme Limited Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives

Also Published As

Publication number Publication date
ATE203531T1 (de) 2001-08-15
GR3036678T3 (en) 2001-12-31
EP0902027B1 (de) 2001-07-25
NZ331683A (en) 2000-01-28
FR2767827A1 (fr) 1999-02-26
ZA988072B (en) 1999-03-09
CN1218052A (zh) 1999-06-02
HU9801977D0 (en) 1998-10-28
US6046205A (en) 2000-04-04
DE69801196T2 (de) 2002-03-14
US6020336A (en) 2000-02-01
EP0902027A1 (de) 1999-03-17
HUP9801977A1 (hu) 2000-11-28
DK0902027T5 (da) 2001-12-03
NO984033D0 (no) 1998-09-02
CN1087741C (zh) 2002-07-17
CA2246485C (fr) 2004-04-20
NO316271B1 (no) 2004-01-05
CA2246485A1 (fr) 1999-03-03
HK1019738A1 (en) 2000-02-25
BR9803318A (pt) 2000-02-08
ES2162404T3 (es) 2001-12-16
PL328323A1 (en) 1999-03-15
JPH11130773A (ja) 1999-05-18
PT902027E (pt) 2001-11-30
DK0902027T3 (da) 2001-10-15
NO984033L (no) 1999-03-04
AU8306898A (en) 1999-03-18
AU736602B2 (en) 2001-08-02
CN1510034A (zh) 2004-07-07

Similar Documents

Publication Publication Date Title
DE69801196D1 (de) Indol- und Indazol-derivate, Verfahren zu deren Herstellung und sie enthaltende Zusammensetzungen
US5789416B1 (en) N6 mono heterocyclic substituted adenosine derivatives
YU5399A (sh) Supstituisani pirido-ili pirimido-derivati koji sadrže 6,6- ili 6,7-biciklične prstenove
FI954651A (fi) Mahdollisesti substituoidut 6,8-kinoliinit
PL327735A1 (en) Novel substituted derivatives of imidazole
BR9608591A (pt) Compostos de imidazol
SE8503680D0 (sv) Indolderivat
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
CA2207404A1 (en) Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
DE69224448D1 (de) Imidazol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
CA2273328A1 (en) 5-cyclo indole compounds as 5-ht1d receptor ligands
DE69329645D1 (de) Imidazol-, triazol- und tetrazolderivate
WO1998052548A3 (de) Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen
DE60205239D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel
MY108739A (en) Imidazole, triazole and tetrazole derivatives
HUT60998A (en) Process for producing 2,3-dichloro-6-aminobenzene derivatives
FR2705345B1 (fr) Procédé de synthèse de 1-alkyl-3-hydroxy-5-halogéno-1,2,4-triazoles et nouveaux dérivés d'hydrazine.
IS3985A (is) Aðferð við framleiðslu á 1,2,3,9-tetrahýdró-9-metýl-3-[(2-metýl-1H-imídazól-1-ýl)metýl]-4H-karbasól-4-ón

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee